Effect of melatonin on the peripheral T lymphocyte cell cycle and levels of reactive oxygen species in patients with premature ovarian failure

Li,Yanmin; Liu,Hongli; Sun,Jing; Tian,Yipeng; Li,Changzhong

doi:10.3892/etm.2016.3833

Effect of melatonin on the peripheral T lymphocyte cell cycle and levels of reactive oxygen species in patients with premature ovarian failure

Authors:
- Yanmin Li
- Hongli Liu
- Jing Sun
- Yipeng Tian
- Changzhong Li
View Affiliations

Affiliations: Department of Gynaecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Obstetrics, Weifang Traditional Chinese Medicine Hospital, Weifang, Shandong 261041, P.R. China, Department of Obstetrics, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
Published online on: October 21, 2016 https://doi.org/10.3892/etm.2016.3833
Pages: 3589-3594
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The objective of the present study was to observe the curative effect and mechanism of melatonin for suppression of premature ovarian failure (POF). From December 2014 to June 2015, 128 patients were consecutively diagnosed with POF in the Department of Gynaecology and Obstetrics. The patients were randomly divided into the experimental and control groups. The experimental group received melatonin tablets (1-3 mg/day), while the control group received placebo tablets. The levels of six sex hormones, percentage of T lymphocytes in the G1/M phase, and levels of reactive oxygen species (ROS) were determined at four different time-points (1 day before treatment, and at 1, 3 and 6 months after treatment) in both groups. After 6 months of treatment, the levels of luteinizing hormone and follicle-stimulating hormone were significantly decreased in the experimental group compared with the control group (P<0.05). Compared with the control group, the levels of ROS in plasma were significantly decreased in the experimental group (P<0.05). Correlation analysis showed that the levels of melatonin in peripheral blood were negatively related with the levels of ROS (rs=-0.481, P<0.05). One-year follow-up study showed that the normal excretion of ovarian hormones in the experimental group was significantly higher than that of the control group (P<0.05). In conclusion, treatment with melatonin is an effective approach to suppress POF. The potential mechanism of melatonin is inhibition of ROS production and protection of the process of normal follicle development.

View Figures

View References

1	Blumenfeld Z and Evron A: Endocrine prevention of chemotherapy-induced ovarian failure. Curr Opin Obstet Gynecol. 28:223–229. 2016. View Article : Google Scholar : PubMed/NCBI
2	Mishra B, Ortiz L and Luderer U: Charged iron particles, components of space radiation, destroy ovarian follicles. Hum Reprod. 31:1816–1826. 2016. View Article : Google Scholar : PubMed/NCBI
3	Roussev RG, Kaider BD, Price DE and Coulam CB: Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol. 35:415–420. 1996. View Article : Google Scholar : PubMed/NCBI
4	Wu X, Cai H, Kallianpur A, Li H, Yang G, Gao J, Xiang YB, Ji BT, Yu-Tang, Zheng W and Shu XO: Impact of premature ovarian failure on mortality and morbidity among Chinese women. PLoS One. 2014.9:e89597 View Article : Google Scholar : PubMed/NCBI
5	Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N and Reiter RJ: Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril. 92:328–343. 2009. View Article : Google Scholar : PubMed/NCBI
6	Jang H, Lee OH, Lee Y, Yoon H, Chang EM, Park M, Lee JW, Hong K, Kim JO, Kim NK, et al: Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary. J Pineal Res. 60:336–347. 2016. View Article : Google Scholar : PubMed/NCBI
7	He H, Jiang DM, Kang B, Ma R, Bai L, Wang X and Zhao L: Gene expression profiling of melatonin receptor subtypes in the ovarian hierarchical follicles of the Sichuan white goose. Anim Reprod Sci. 145:62–68. 2014. View Article : Google Scholar : PubMed/NCBI
8	Ma Q, Zhang T, Zhang P and Wang ZY: Melatonin attenuates postharvest physiological deterioration of cassava storage roots. J Pineal Res. 60:424–434. 2016. View Article : Google Scholar : PubMed/NCBI
9	Gurer-Orhan H, Karaaslan C, Ozcan S, Firuzi O, Tavakkoli M, Saso L and Suzen S: Novel indole-based melatonin analogues: evaluation of antioxidant activity and protective effect against amyloid β-induced damage. Bioorg Med Chem. 24:1658–1664. 2016. View Article : Google Scholar : PubMed/NCBI
10	Lohana CK and Samir N: Risk management of osteoporosis in postmenopausal women; a study of women in a teaching hospital. Glob J Health Sci. 8:555052016.
11	Vriend J and Reiter RJ: Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: a review. Biochim Biophys Acta. 1865:176–183. 2016.PubMed/NCBI
12	Xu Y, Wang S, Jiang L, Wang H, Yang Y, Li M, Wang X, Zhao X and Xie K: Identify melatonin as a novel therapeutic reagent in the treatment of 1-bromopropane(1-BP) intoxication. Medicine (Baltimore). 95:e22032016. View Article : Google Scholar : PubMed/NCBI
13	Rhee YH and Ahn JC: Melatonin attenuated adipogenesis through reduction of the CCAAT/enhancer binding protein beta by regulating the glycogen synthase 3 beta in human mesenchymal stem cells. J Physiol Biochem. 72:145–155. 2016. View Article : Google Scholar : PubMed/NCBI
14	Xie JY, He W, Zhao LM, Chen M and Liang ZQ: The changes of CD4⁻ CD25⁻ regulatory T cells and changes of interferon gamma and expression of transforming growth factor beta 1 in patients with premature ovarian failure. West China Med J. 3:377–379. 2013.(In Chinese).
15	Bodas M, Van Westphal C, Carpenter-Thompson R, Mohanty KD and Vij N: Nicotine exposure induces bronchial epithelial cell apoptosis and senescence via ROS mediated autophagy-impairment. Free Radic Biol Med. 97:441–453. 2016. View Article : Google Scholar : PubMed/NCBI
16	Mehrzadi S, Kamrava SK, Dormanesh B, Motevalian M, Hosseinzadeh A, Tabatabaei SM Hosseini and Ghaznavi H: Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney. Can J Physiol Pharmacol. 94:265–271. 2016. View Article : Google Scholar : PubMed/NCBI
17	Check JH, Wilson C, DiAntonio G and DiAntonio A: In vitro fertilization (IVF) outcome in women in overt menopause attempting to induce follicular maturation by follicle stimulating hormone (FSH) receptor down-regulation. Clin Exp Obstet Gynecol. 43:181–183. 2016.PubMed/NCBI
18	Sundaresan NR, Leo MD Marcus, Subramani J, Anish D, Sudhagar M, Ahmed KA, Saxena M, Tyagi JS, Sastry KV and Saxena VK: Expression analysis of melatonin receptor subtypes in the ovary of domestic chicken. Vet Res Commun. 33:49–56. 2009. View Article : Google Scholar : PubMed/NCBI
19	Liu T, Li Q, Wang S, Chen C and Zheng J: Transplantation of ovarian granulosa-like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure. Mol Med Rep. 13:5053–5058. 2016.PubMed/NCBI
20	Kleszczyñski K, Zillikens D and Fischer TW: Melatonin enhances mitochondrial ATP synthesis, reduces ROS formation and mediates translocation of the nuclear erythroid 2-related factor 2 resulting in activation of phase-2 antioxidant enzymes (ã-GCS, HO-1, NQO1) in UVR-treated normal human epidermal keratinocytes (NHEK). J Pineal Res. (In press). 2016. View Article : Google Scholar
21	Benedict C, Thom B, N Friedman D, Diotallevi D, M Pottenger E, Raghunathan JN and Kelvin JF: Young adult female cancer survivors' unmet information needs and reproductive concerns contribute to decisional conflict regarding posttreatment fertility preservation. Cancer. 122:2101–2109. 2016. View Article : Google Scholar : PubMed/NCBI
22	Laisk-Podar T, Lindgren CM, Peters M, Tapanainen JS, Lambalk CB, Salumets A and Mägi R: Ovarian physiology and GWAS: biobanks, biology, and beyond. Trends Endocrinol Metab. 27:516–528. 2016. View Article : Google Scholar : PubMed/NCBI